At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing ...
2025 FEB 27 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- New research on Opioids is the subject of a report. According to news reporting originating in New Albany, Ohio, ...
September 28, 2010 (Las Vegas, Nevada) — A transdermal application system containing the partial μ-opioid receptor agonist buprenorphine showed analgesic efficacy in the treatment of low back pain in ...
Nutriband Inc. (NASDAQ:NTRB) is a pharmaceutical company with a specific focus on developing a portfolio of transdermal pharmaceutical products. The company’s lead product under development is AVERSA™ ...
Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...
Opioid analgesics remain the most effective available therapy, but side effects limit their use. The most important advances in the pharmacology of opioids are related to new formulations and novel ...
ORLANDO, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it ...
Millions of people across the world suffer from pain. Chronic discomfort is an unfortunate reality, whether from an accident or serious illness. Luckily, access to medications and alleviation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results